In this study, all 3 primary CNS A-DLBCL patients displayed mutations in MYD88 L265P, which is consistent with the high frequency of MYD88 alterations reported in the literature for primary CNS DLBCL. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.